AU2002336148A1 - Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine - Google Patents

Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

Info

Publication number: AU2002336148A1
Authority: AU; Australia
Prior art keywords: rsv; vaccine; protein; respiratory syncytial; syncytial virus
Prior art date: 2001-07-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002336148A

Other versions

AU2002336148B8 (en

AU2002336148B2 (en

Inventor

Alain Beck

Nathalie Corvaia

Thien Nguyen Ngoc

Helene Plotnicky

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-20

Filing date

2002-07-19

Publication date

2003-05-29

2001-07-20 Priority claimed from FR0109731A external-priority patent/FR2827605B1/en

2002-07-19 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

2003-05-29 Publication of AU2002336148A1 publication Critical patent/AU2002336148A1/en

2007-12-13 Application granted granted Critical

2007-12-13 Publication of AU2002336148B2 publication Critical patent/AU2002336148B2/en

2008-06-19 Publication of AU2002336148B8 publication Critical patent/AU2002336148B8/en

2022-07-19 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR01/09731		2001-07-20
FR0109731A FR2827605B1 (en)	2001-07-20	2001-07-20	NOVEL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE
PCT/FR2002/002599 WO2003010317A1 (en)	2001-07-20	2002-07-19	Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine

Publications (3)

Publication Number	Publication Date
AU2002336148A1 true AU2002336148A1 (en)	2003-05-29
AU2002336148B2 AU2002336148B2 (en)	2007-12-13
AU2002336148B8 AU2002336148B8 (en)	2008-06-19

Family

ID=8865750

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002336148A Ceased AU2002336148B8 (en)	2001-07-20	2002-07-19	Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

Country Status (16)

Country	Link
US (3)	US7309494B2 (en)
EP (1)	EP1409692B1 (en)
JP (1)	JP4310184B2 (en)
CN (1)	CN1556857A (en)
AT (1)	ATE408696T1 (en)
AU (1)	AU2002336148B8 (en)
BR (1)	BR0211296A (en)
CA (1)	CA2455360A1 (en)
DE (1)	DE60228971D1 (en)
DK (1)	DK1409692T3 (en)
ES (1)	ES2314102T3 (en)
FR (1)	FR2827605B1 (en)
MX (1)	MXPA04000597A (en)
PT (1)	PT1409692E (en)
WO (1)	WO2003010317A1 (en)
ZA (1)	ZA200400916B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2426312C (en)	2000-10-18	2014-01-14	Ralph A. Tripp	Compositions and methods for modulating rsv infection and immunity
WO2006023029A2 (en) *	2004-06-16	2006-03-02	The Johns Hopkins University	The cysteine-rich region of respiratory syncytial virus and methods of use therefor
EP1972348A1 (en) *	2007-03-14	2008-09-24	Pierre Fabre Medicament	Novel vaccine composition for the treatment of respiratory infectious diseases
NZ591768A (en)	2008-09-18	2012-11-30	Novartis Ag	Vaccine adjuvant combinations
CA2770304C (en)	2009-08-04	2019-11-26	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention	Anti-rsv immunogens and methods of immunization
NZ598459A (en)	2009-08-27	2014-03-28	Novartis Ag	Adjuvant comprising aluminium, oligonucleotide and polycation
EA026401B1 (en)	2009-09-02	2017-04-28	Новартис Аг	Immunogenic compositions including tlr activity modulators
EP2818182B1 (en)	2009-12-21	2016-04-27	Cornell University	Novel pneumovirus compositions and methods for using the same
US20120177681A1 (en)	2010-09-01	2012-07-12	Manmohan Singh	Formulation of immunopotentiators
WO2012082914A1 (en)	2010-12-14	2012-06-21	Novartis Ag	Flow cytometry analysis of materials adsorbed to metal salts
CA2828844C (en)	2011-03-02	2020-07-14	Novartis Ag	Combination vaccines with lower doses of antigen and/or adjuvant
WO2012138774A2 (en)	2011-04-04	2012-10-11	University Of Iowa Research Foundation	Methods of improving vaccine immunogenicity
ES2395677B1 (en) *	2011-07-29	2013-12-26	Instituto De Salud Carlos Iii	VRSH F protein in stabilized pre-fusion conformation and specific neutralizing antibodies against it.
CN103239734B (en) *	2012-02-10	2016-02-24	北京艾棣维欣生物技术有限公司	For preventing and/or treating the vaccine of respiratory syncytial virus infection
CN104519910B (en)	2012-03-07	2017-05-03	诺华股份有限公司	Adjuvanted formulations of streptococcus pneumoniae antigens
SI2822947T1 (en)	2012-03-07	2016-10-28	Glaxosmithkline Biologicals S.A.	Arginine salts of a tlr7 agonist
MX372965B (en)	2012-03-08	2020-04-01	Glaxosmithkline Biologicals Sa	ADJUVATED FORMULATIONS OF DIPHTHERIA, TETANUS AND PERTUSSUS (DTP) BOOSTER VACCINES.
JP6523955B2 (en)	2012-08-01	2019-06-05	バヴァリアン・ノルディック・アクティーゼルスカブ	Recombinant modified vaccinia virus Ankara (MVA) RS virus (RSV) vaccine
CN105085684B (en) *	2014-05-14	2020-04-17	上海亨臻实业有限公司	Design and application of PCSK9 targeted recombinant vaccine
WO2016160166A1 (en) *	2015-03-30	2016-10-06	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Immunogenic rsv polypeptides
AU2017220387B9 (en)	2016-02-16	2021-07-22	The University Of Queensland	Novel alpha conotoxin peptides
CN105542003B (en) *	2016-03-01	2019-12-06	苏州博泰神州生物技术有限公司	Fully human monoclonal antibody aiming at RSV (respiratory syncytial virus) adhesion G protein surface antigen
US20220411783A1 (en) *	2018-10-12	2022-12-29	The Broad Institute, Inc.	Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
CA3130433A1 (en)	2019-02-28	2020-09-03	Km Biologics Co., Ltd.	Rsv f/g chimeric vaccine
US11360877B2 (en) *	2020-09-14	2022-06-14	International Business Machines Corporation	Forming microservices from monolithic applications
WO2024084785A1 (en) *	2022-10-20	2024-04-25	一般財団法人阪大微生物病研究会	Composition suitable for use as rs virus vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3689622T2 (en)	1986-01-14	1994-06-16	Univ North Carolina	Vaccines against human respiratory viruses.
US5223254A (en)	1987-09-29	1993-06-29	Praxis Biologics, Inc.	Respiratory syncytial virus: vaccines
FR2718452B1 (en) *	1994-04-06	1996-06-28	Pf Medicament	Element of immunogen, immunogenic agent, pharmaceutical composition and method of preparation.
AUPO026596A0 (en)	1996-06-05	1996-06-27	Biomolecular Research Institute Limited	Viral peptide
FR2766192B1 (en)	1997-07-17	2001-07-13	Pf Medicament	EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY
FR2776521B1 (en)	1998-03-27	2000-12-15	Pf Medicament	USE OF P40 ACTIVE CONJUGATES BY NASAL
FR2798857B1 (en) *	1999-09-23	2003-06-06	Pf Medicament	USE OF AN OMPA MEMBRANE PROTEIN OF ENTEROBACTERIA ASSOCIATED WITH AN RSV IMMUNOGENIC PEPTIDE FOR THE PREPARATION OF NASAL ADMINISTRATIVE VACCINES

2001
- 2001-07-20 FR FR0109731A patent/FR2827605B1/en not_active Expired - Fee Related
2002
- 2002-07-19 US US10/484,298 patent/US7309494B2/en not_active Expired - Fee Related
- 2002-07-19 WO PCT/FR2002/002599 patent/WO2003010317A1/en active IP Right Grant
- 2002-07-19 AT AT02770043T patent/ATE408696T1/en not_active IP Right Cessation
- 2002-07-19 JP JP2003515667A patent/JP4310184B2/en not_active Expired - Fee Related
- 2002-07-19 ES ES02770043T patent/ES2314102T3/en not_active Expired - Lifetime
- 2002-07-19 DK DK02770043T patent/DK1409692T3/en active
- 2002-07-19 MX MXPA04000597A patent/MXPA04000597A/en active IP Right Grant
- 2002-07-19 DE DE60228971T patent/DE60228971D1/en not_active Expired - Fee Related
- 2002-07-19 BR BR0211296-5A patent/BR0211296A/en not_active IP Right Cessation
- 2002-07-19 PT PT02770043T patent/PT1409692E/en unknown
- 2002-07-19 EP EP02770043A patent/EP1409692B1/en not_active Expired - Lifetime
- 2002-07-19 CN CNA028184475A patent/CN1556857A/en active Pending
- 2002-07-19 AU AU2002336148A patent/AU2002336148B8/en not_active Ceased
- 2002-07-19 CA CA002455360A patent/CA2455360A1/en not_active Abandoned
2004
- 2004-02-04 ZA ZA200400916A patent/ZA200400916B/en unknown
2007
- 2007-11-16 US US11/985,839 patent/US7524627B2/en not_active Expired - Fee Related
2009
- 2009-03-02 US US12/380,671 patent/US20090181042A1/en not_active Abandoned

Similar Documents

Publication	Publication Date	Title
AU2002336148A1 (en)	2003-05-29	Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
GB2376685B (en)	2003-07-30	Anti-inflammatory and immunomodulatory amino acid derivatives,their preparation and use
AU2001286171A1 (en)	2003-05-08	Human cDNAs and proteins and uses thereof
AU2002234643A1 (en)	2003-02-27	Amphoteric liposomes and the use thereof
AU2002255952A1 (en)	2002-10-15	Short bioactive peptides and methods for their use
EP1414848A4 (en)	2006-07-19	Replikin peptides and uses thereof
EP1462455A4 (en)	2008-12-31	Novel peptides and medicinal uses thereof
AU2002233457A1 (en)	2002-08-06	Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
EP1419175A4 (en)	2006-07-19	Replikin peptides and uses thereof
AU2002343462A1 (en)	2003-04-14	Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof
AU2002233424A1 (en)	2003-02-06	Peptides having affinity for the GP120 viral protein and use thereof
AU2001278337A1 (en)	2002-02-13	Respiratory syncytial virus vaccine
IL162134A0 (en)	2005-11-20	Human cDNAs and proteins, and uses thereof
AU2003242222A1 (en)	2003-12-31	A recombinant anti-enveloped virus peptide and its preparation
AU2003231980A1 (en)	2003-10-13	Identification of apoptotic peptides and methods of use thereof
AU2002312373A1 (en)	2002-12-23	Structural and cytoskeleton-associated proteins
AU2002230129A1 (en)	2002-08-19	Novel physiologically active peptide and use thereof
AU2002343042A8 (en)	2003-06-10	Virulence proteins of the genus yersinia and uses thereof
AUPR595601A0 (en)	2001-07-19	Hypoglycaemic peptides and methods of use thereof
AUPR548601A0 (en)	2001-06-28	Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002338856A1 (en)	2003-03-24	Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
AU2001248750A1 (en)	2001-10-23	Novel physiologically active peptides and use thereof
AU2002320621A1 (en)	2003-03-03	Structural and cytoskeleton-associated proteins
AU2002354188B2 (en)	2008-11-27	Novel peptides and medicinal uses thereof
AUPR589701A0 (en)	2001-07-19	Novel peptide and use thereof